These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23283737)

  • 1. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.
    Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I
    Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection.
    Yang L; Ji Y; Chen L; Li M; Wu F; Hu J; Jiang J; Cui X; Chen Y; Pang L; Wei Y; Li F
    PLoS One; 2017; 12(10):e0186319. PubMed ID: 29073155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.
    Pan QF; Li WT; Dong HC; Chen YZ; Yin L; Liu W; Wang WW; Liu D; Li SG; Gu WY; Chen JZ; Yang L; Zhang WJ; Li F
    Dis Esophagus; 2014; 27(4):396-402. PubMed ID: 23980519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
    Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
    Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
    Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
    Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
    Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
    J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.
    Cui X; Chen X; Wang W; Chang A; Yang L; Liu C; Peng H; Wei Y; Liang W; Li S; Wang N; Liu W; Hu J; Zhang W; Wang L; Chen Y; Li F
    Epigenetics; 2017 Aug; 12(8):698-707. PubMed ID: 28703658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
    Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma.
    Liu L; Zhang S; Liu X; Liu J
    Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
    Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
    Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.